按相关排序
全部格式
全部页数
时间不限
只看优质
只看可投资
展开
排序：
相关 最多阅读 最新上传
格式：
全部 doc pdf ppt xls txt 豆单
页数：
全部 1-8页 9-100页 100页以上
时间：
全部 2024年 2023年 2022年及以前
23
Curcumin A Potent Candidate to be Evaluated as a Chemosensitizer in Paclitaxel Chemotherapy Against Cervical Cancer.pdf
Curcumin A Potent Candidate to be Evaluated as a Chemosensitizer in Paclitaxel Chemotherapy Against Cervical Cancer
收藏到书房
立即下载
13
dibi, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promot.pdf
dibi, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promot
收藏到书房
立即下载
32
CURCUMIN AS CHEMOSENSITIZER.pdf
CURCUMIN AS CHEMOSENSITIZER
收藏到书房
立即下载
12
therapeutic potential of antisense bcl-2 as a chemosensitizer for cancer therapy.pdf
therapeutic potential of antisense bcl-2 as a chemosensitizer for cancer therapy
收藏到书房
立即下载
10
preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma.pdf
preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma
收藏到书房
立即下载
12
effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (sgc7901) cells.pdf
effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (sgc7901) cells
收藏到书房
立即下载
8
Double-Edged Sword of Chemosensitizer Increase of Multidrug Resistance Protein (MRP) in Leukemic Cells by an MRP Inhibitor Probenecid.pdf
Double-Edged Sword of Chemosensitizer Increase of Multidrug Resistance Protein (MRP) in Leukemic Cells by an MRP Inhibitor Probenecid
收藏到书房
立即下载
3
Nanopotentiated combination cancer therapy Chemotherapeutic and chemosensitizer (2C approach).pdf
Nanopotentiated combination cancer therapy Chemotherapeutic and chemosensitizer (2C approach)
收藏到书房
立即下载
1
Physical exercise as chemosensitizer.pdf
Physical exercise as chemosensitizer
收藏到书房
立即下载

向豆丁求助：有没有chemosensitizer?

如要投诉违规内容，请联系我们按需举报；如要提出意见建议，请到社区论坛发帖反馈。